India News | Press Trust of India | Thursday January 12, 2023
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
www.ndtv.com